169 related articles for article (PubMed ID: 20398848)
21. Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapy.
Iyer R; Wilkinson N; Demmy T; Javle M
Ann Surg Oncol; 2004 Jul; 11(7):665-73. PubMed ID: 15197012
[TBL] [Abstract][Full Text] [Related]
22. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis.
Malthaner RA; Wong RK; Rumble RB; Zuraw L;
BMC Med; 2004 Sep; 2():35. PubMed ID: 15447788
[TBL] [Abstract][Full Text] [Related]
24. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
National Institutes of Health Consensus Development Panel
J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
[TBL] [Abstract][Full Text] [Related]
25. [Neoadjuvant therapy for resectable esophageal cancer].
Hejna M; Raderer M
Z Gastroenterol; 2005 Oct; 43(10):1141-7. PubMed ID: 16220454
[TBL] [Abstract][Full Text] [Related]
26. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
27. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer.
Geh JI; Crellin AM; Glynne-Jones R
Br J Surg; 2001 Mar; 88(3):338-56. PubMed ID: 11260097
[TBL] [Abstract][Full Text] [Related]
28. [Current status of combined modality therapy for esophageal cancer: from the standpoint of medical oncology].
Ohtsu A
Gan To Kagaku Ryoho; 1998 Jan; 25(2):232-40. PubMed ID: 9474933
[TBL] [Abstract][Full Text] [Related]
29. Preoperative chemotherapy for resectable thoracic esophageal cancer.
Malthaner R; Fenlon D
Cochrane Database Syst Rev; 2003; (4):CD001556. PubMed ID: 14583936
[TBL] [Abstract][Full Text] [Related]
30. Preoperative chemotherapy for resectable thoracic esophageal cancer.
Kidane B; Coughlin S; Vogt K; Malthaner R
Cochrane Database Syst Rev; 2015 May; 2015(5):CD001556. PubMed ID: 25988291
[TBL] [Abstract][Full Text] [Related]
31. Preoperative chemotherapy for resectable thoracic esophageal cancer.
Malthaner RA; Collin S; Fenlon D
Cochrane Database Syst Rev; 2006 Jul; (3):CD001556. PubMed ID: 16855972
[TBL] [Abstract][Full Text] [Related]
32. The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer: a practice guideline.
Figueredo A; Zuraw L; Wong RK; Agboola O; Rumble RB; Tandan V;
BMC Med; 2003 Nov; 1():1. PubMed ID: 14633275
[TBL] [Abstract][Full Text] [Related]
33. American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays.
Burstein HJ; Mangu PB; Somerfield MR; Schrag D; Samson D; Holt L; Zelman D; Ajani JA;
J Clin Oncol; 2011 Aug; 29(24):3328-30. PubMed ID: 21788567
[TBL] [Abstract][Full Text] [Related]
34. American Society of Clinical Oncology endorsement of the cancer care Ontario practice guideline on adjuvant ovarian ablation in the treatment of premenopausal women with early-stage invasive breast cancer.
Griggs JJ; Somerfield MR; Anderson H; Henry NL; Hudis CA; Khatcheressian JL; Partridge AH; Prestrud AA; Davidson NE
J Clin Oncol; 2011 Oct; 29(29):3939-42. PubMed ID: 21900112
[TBL] [Abstract][Full Text] [Related]
35. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.
Sjoquist KM; Burmeister BH; Smithers BM; Zalcberg JR; Simes RJ; Barbour A; Gebski V;
Lancet Oncol; 2011 Jul; 12(7):681-92. PubMed ID: 21684205
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a clinical practice guideline.
Malthaner RA; Wong RK; Rumble RB; Zuraw L;
BMC Cancer; 2004 Sep; 4():67. PubMed ID: 15447791
[TBL] [Abstract][Full Text] [Related]
37. Combined-modality treatment of esophageal cancer.
Urba S
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 9):63-7. PubMed ID: 9330411
[TBL] [Abstract][Full Text] [Related]
38. Resectable esophageal cancer: surgery as primary therapy is not the answer, but then, what is and why?
Ajani JA
J Clin Oncol; 2010 May; 28(15):e243-4; author reply e245. PubMed ID: 20368554
[No Abstract] [Full Text] [Related]
39. [Radiotherapy and chemotherapy for esophageal cancer].
Masamichi N
Nihon Geka Gakkai Zasshi; 2002 Apr; 103(4):364-70. PubMed ID: 11993226
[TBL] [Abstract][Full Text] [Related]
40. A systematic overview of radiation therapy effects in oesophageal cancer.
Ask A; Albertsson M; Järhult J; Cavallin-Ståhl E
Acta Oncol; 2003; 42(5-6):462-75. PubMed ID: 14596507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
